financetom
Business
financetom
/
Business
/
Parker-Hannifin's Healthy Outlook, Increased M&A Appetite Makes It Attractive, Says Analyst
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Parker-Hannifin's Healthy Outlook, Increased M&A Appetite Makes It Attractive, Says Analyst
May 28, 2024 10:57 AM

Mizuho Securities analyst Brett Linzey upgraded the shares of Parker-Hannifin Corp ( PH ) from Neutral to Buy and raised the price target from $550 to $650.

The upgrade and the rise in price target come after the company announced its five-year financial targets during the investor’s day event.

PH sees 4%-6% organic sales growth CAGR through 2029, 27% adjusted operating margin, 28% adjusted EBITDA margin and a 10%+ adjusted EPS CAGR.

Execution has been rock solid and the company has established one of the more credible track records in the coverage universe, says the analyst.

PH has established profit margin targets four times in the last ten years and has exceeded each ahead of schedule, paving the way for more upside conversion, noted the analyst.

According to the analyst, Aerospace & Defense is now one-third of the business mix and is expected to grow in the high-single digit through FY29, driven by air traffic growth and new deliveries.

Electrification and clean technology trends are expected to be key growth drivers across two-thirds of the portfolio inclusive of Aero, said the analyst.

Parker rolled forward its FY27 targets to FY29 with a healthy increase in the margin outlook, asserted the analyst.

The analyst said each reported business segment has room for upside and should contribute to the ~240bps needed to hit the new ~27% operating margin target.

Recent mergers and acquisitions such as Clarcor, Lord, Exotic, and Meggitt have achieved the cost synergy targets implemented by management, noted the analyst.

PH stock has underperformed by ~700bps vs. the group over the past month after solid trading performance to start ’24, said the analyst.

Price Action: PH shares are trading lower by 0.09% at $529.33 at the last check Tuesday.

Image from Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla's sales in Sweden fall 53.7% year-on-year in May
Tesla's sales in Sweden fall 53.7% year-on-year in May
Jun 2, 2025
STOCKHOLM (Reuters) -Tesla's new car sales in Sweden fell 53.7% in May from a year earlier to 503 vehicles, registration data from Mobility Sweden showed on Monday. ...
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
Jun 2, 2025
FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker has pioneered. The Swiss drugmaker reported a late-stage trial showed a clinically meaningful benefit in progression-free survival with a positive...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sanofi to buy US biopharma group Blueprint for over $9 billion
Sanofi to buy US biopharma group Blueprint for over $9 billion
Jun 2, 2025
* Sanofi to pay $129 per share in cash * Deal to enhance Sanofi's rare and immunology portfolios * Would be one of biggest in Europe so far this year (Adds details and background throughout, shares) PARIS, June 2 (Reuters) - France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation ( BPMC ) for over $9 billion to boost...
Copyright 2023-2026 - www.financetom.com All Rights Reserved